AstraZeneca (cancer drug) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
AstraZeneca (cancer drug) General Information
Description
Cancer drug of AstraZenca. The drug, Caprelsa is used for the treatment of aggressive and symptomatic medullary thyroid carcinoma.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- London
- England, United Kingdom
AstraZeneca (cancer drug) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AstraZeneca (cancer drug) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|